Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Ceftobiprole

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innoviva’s ZEVTERA, XACDURO Nominated for 2025 Prix Galien
    Innoviva’s ZEVTERA, XACDURO Nominated for 2025 Prix Galien

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250813478127/en/Innoviva-Specialty-Therapeutics-Antimicrobial-Therapies-ZEVTERA-and-XACDURO-Nominated-for-the-2025-Prix-Galien-USA-Best-Pharmaceutical-Product-Award

    BUSINESSWIRE
    13 Aug 2025
    Share Share
    Zevtra Available in US for 3 Bacterial Infection
    Zevtra Available in US for 3 Bacterial Infection

    20 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250520570730/en/ZEVTERA-ceftobiprole-an-Advanced-Generation-Cephalosporin-Antibiotic-Now-Commercially-Available-in-the-U.S.-to-Treat-Three-Types-of-Bacterial-Infections

    BUSINESSWIRE
    20 May 2025
    Share Share
    Basilea Presents Data for Fosmanogepix, Isavuconazole, & Ceftobiprole
    Basilea Presents Data for Fosmanogepix, Isavuconazole, & Ceftobiprole

    16 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/16/3062270/0/en/Basilea-reports-presentation-of-new-data-for-fosmanogepix-isavuconazole-Cresemba-and-ceftobiprole-Zevtera-at-ESCMID-Global-2025.html

    GLOBENEWSWIRE
    16 Apr 2025
    Share Share
    Sales growth for Cresemba & Zevtera trigger payments to Basilea
    Sales growth for Cresemba & Zevtera trigger payments to Basilea

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016062/0/en/Strong-sales-growth-for-Cresemba-and-Zevtera-trigger-further-milestone-payments-to-Basilea.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share
    Innoviva Signs Exclusive Deal to Acquire Zevtera® U.S. Rights
    Innoviva Signs Exclusive Deal to Acquire Zevtera® U.S. Rights

    16 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241216588264/en

    BUSINESSWIRE
    16 Dec 2024
    Share Share
    Basilea Presents New Ceftobiprole Data At ESCMID Global 2024
    Basilea Presents New Ceftobiprole Data At ESCMID Global 2024

    03 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/03/2874833/0/en/Basilea-reports-presentation-of-new-data-for-ceftobiprole-Zevtera-at-ESCMID-Global-2024.html

    GLOBENEWSWIRE
    03 May 2024
    Share Share